Stay updated on Study Nesvacumab in AMD Clinical Trial

Sign up to get notified when there's something new on the Study Nesvacumab in AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study Nesvacumab in AMD Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record presents details of Regeneron’s completed Phase 1 nesvacumab study, including its participant criteria, treatment cohorts, measured outcomes, and study locations.
    Difference
    40%
    Check dated 2026-11-08T04:32:58.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer revision identifier was updated from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:38:28.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:36:49.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:16:59.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:45:56.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, with the 403 HTML and message visible on the screen. The previous study details and navigation are replaced by the error view, indicating the content is not accessible on this page.
    Difference
    16%
    Check dated 2026-09-20T00:38:13.000Z thumbnail image

Stay in the know with updates to Study Nesvacumab in AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study Nesvacumab in AMD Clinical Trial page.